Last 12 months
Inside the activity.
0 purchase rows · 54 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 10 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 5 |
| May 2026 | 0 | 12 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2024 Filed Feb 26, 2024 22:52 UTC |
GALLAHUE KIERANDirector
|
GiftCommon Stock | 7,056 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002963 · doc4.xml · nonDerivative · entry 3 GALLAHUE KIERAN · CIK 0001308428 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 70,277 Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 22:52 UTC |
GALLAHUE KIERANDirector
|
GiftCommon Stock | 7,056 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002963 · doc4.xml · nonDerivative · entry 2 GALLAHUE KIERAN · CIK 0001308428 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,701 Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 22:52 UTC |
GALLAHUE KIERANDirector
|
Exercise / conversionCommon Stock | 7,056 | $36.86 | $260,107.44 |
DisclosureSEC source: 0001225208-24-002963 · doc4.xml · nonDerivative · entry 1 GALLAHUE KIERAN · CIK 0001308428 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,757 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 23:51 UTC |
SELLERS ROBERT W.A.SVP, Corporate Controller
|
GrantCommon Stock | 1,998 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002857 · doc4.xml · nonDerivative · entry 1 SELLERS ROBERT W.A. · CIK 0001600739 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,085.1838 F1 · shares: These restricted stock units were granted on February 22, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 23:51 UTC |
Szyman Catherine M.CVP, Critical Care
|
GrantCommon Stock | 8,560 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002856 · doc4.xml · nonDerivative · entry 1 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,373.571 F1 · shares: These restricted stock units were granted on February 22, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. Read SEC document |
| February 21, 2024 Filed Feb 21, 2024 22:52 UTC |
Chopra DaveenCVP, TMTT
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 7,000 | $0.00 Strike: $59.26 | $0.00 |
DisclosureSEC source: 0001225208-24-002654 · doc4.xml · derivative · entry 4 Chopra Daveen · CIK 0001740963 · CVP, TMTT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2026-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2024 Filed Feb 21, 2024 22:52 UTC |
Chopra DaveenCVP, TMTT
|
SaleCommon Stock | 7,000 | $86.75 | $607,267.50 |
DisclosureSEC source: 0001225208-24-002654 · doc4.xml · nonDerivative · entry 3 Chopra Daveen · CIK 0001740963 · CVP, TMTT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,750 F2 · price: This transaction was executed in multiple trades at prices ranging from $86.7455 to $86.7600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 21, 2024 Filed Feb 21, 2024 22:52 UTC |
Chopra DaveenCVP, TMTT
|
SaleCommon Stock | 1,200 | $86.67 | $104,004.24 |
DisclosureSEC source: 0001225208-24-002654 · doc4.xml · nonDerivative · entry 2 Chopra Daveen · CIK 0001740963 · CVP, TMTT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,750 F1 · price: This transaction was executed in multiple trades at prices ranging from $86.6600 to $86.6800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 21, 2024 Filed Feb 21, 2024 22:52 UTC |
Chopra DaveenCVP, TMTT
|
Exercise / conversionCommon Stock | 7,000 | $59.26 | $414,796.90 |
DisclosureSEC source: 0001225208-24-002654 · doc4.xml · nonDerivative · entry 1 Chopra Daveen · CIK 0001740963 · CVP, TMTT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2024 Filed Feb 20, 2024 22:49 UTC |
Lippis Daniel J.CVP, JAPAC
|
Tax withholdingCommon Stock | 188 | $86.10 | $16,186.80 |
DisclosureSEC source: 0001225208-24-002520 · doc4.xml · nonDerivative · entry 3 Lippis Daniel J. · CIK 0002004380 · CVP, JAPAC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,213.2105 Read SEC document |
| February 17, 2024 Filed Feb 20, 2024 22:49 UTC |
Lippis Daniel J.CVP, JAPAC
|
Tax withholdingCommon Stock | 150 | $86.10 | $12,915.00 |
DisclosureSEC source: 0001225208-24-002520 · doc4.xml · nonDerivative · entry 2 Lippis Daniel J. · CIK 0002004380 · CVP, JAPAC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,401.2105 Read SEC document |
| February 16, 2024 Filed Feb 16, 2024 23:40 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 174 | $86.04 | $14,970.96 |
DisclosureSEC source: 0001225208-24-002345 · doc4.xml · nonDerivative · entry 1 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,074 Read SEC document |
| February 16, 2024 Filed Feb 16, 2024 23:39 UTC |
Wood Larry LGlobal President TAVR & Surg
|
Tax withholdingCommon Stock | 317 | $86.04 | $27,274.68 |
DisclosureSEC source: 0001225208-24-002344 · doc4.xml · nonDerivative · entry 1 Wood Larry L · CIK 0001440660 · Global President TAVR & Surg 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,476.7137 Read SEC document |
| February 16, 2024 Filed Feb 20, 2024 22:49 UTC |
Lippis Daniel J.CVP, JAPAC
|
Tax withholdingCommon Stock | 207 | $86.04 | $17,810.28 |
DisclosureSEC source: 0001225208-24-002520 · doc4.xml · nonDerivative · entry 1 Lippis Daniel J. · CIK 0002004380 · CVP, JAPAC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,551.2105 Read SEC document |
| February 15, 2024 Filed Feb 15, 2024 22:25 UTC |
Szyman Catherine M.CVP, Critical Care
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 27,000 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001225208-24-002191 · doc4.xml · derivative · entry 6 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,000 shares Expires 2024-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2024 Filed Feb 15, 2024 22:25 UTC |
Szyman Catherine M.CVP, Critical Care
|
SaleCommon Stock | 27,000 | $85.62 | $2,311,653.60 |
DisclosureSEC source: 0001225208-24-002191 · doc4.xml · nonDerivative · entry 4 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,813.571 F2 · price: This transaction was executed in multiple trades at prices ranging from $85.44 to $85.83. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 15, 2024 Filed Feb 15, 2024 22:25 UTC |
Szyman Catherine M.CVP, Critical Care
|
Exercise / conversionCommon Stock | 27,000 | $36.75 | $992,250.00 |
DisclosureSEC source: 0001225208-24-002191 · doc4.xml · nonDerivative · entry 3 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,813.571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2024 Filed Feb 13, 2024 21:51 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 11,000 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001225208-24-001949 · doc4.xml · derivative · entry 6 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,000 Underlying: Common Stock · 11,000 shares Expires 2024-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2024 Filed Feb 13, 2024 21:51 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
SaleCommon Stock | 10,530 | $85.81 | $903,572.98 |
DisclosureSEC source: 0001225208-24-001949 · doc4.xml · nonDerivative · entry 3 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,502.6931 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $85.33 to $86.30. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 13, 2024 Filed Feb 13, 2024 21:51 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
SaleCommon Stock | 470 | $86.35 | $40,582.48 |
DisclosureSEC source: 0001225208-24-001949 · doc4.xml · nonDerivative · entry 2 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,032.6931 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $86.34 to $86.35. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 13, 2024 Filed Feb 13, 2024 21:51 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionCommon Stock | 11,000 | $36.75 | $404,250.00 |
DisclosureSEC source: 0001225208-24-001949 · doc4.xml · nonDerivative · entry 1 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,502.6931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 22:25 UTC |
Szyman Catherine M.CVP, Critical Care
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 20,000 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001225208-24-002191 · doc4.xml · derivative · entry 5 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,000 Underlying: Common Stock · 20,000 shares Expires 2024-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 22:25 UTC |
Szyman Catherine M.CVP, Critical Care
|
SaleCommon Stock | 20,000 | $86.46 | $1,729,200.00 |
DisclosureSEC source: 0001225208-24-002191 · doc4.xml · nonDerivative · entry 2 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,813.571 F1 · price: This transaction was executed in multiple trades at prices ranging from $86.00 to $86.81. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 22:25 UTC |
Szyman Catherine M.CVP, Critical Care
|
Exercise / conversionCommon Stock | 20,000 | $36.75 | $735,000.00 |
DisclosureSEC source: 0001225208-24-002191 · doc4.xml · nonDerivative · entry 1 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,813.571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2024 Filed Feb 12, 2024 22:44 UTC |
SELLERS ROBERT W.A.SVP, Corporate Controller
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 12,210 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001225208-24-001867 · doc4.xml · derivative · entry 4 SELLERS ROBERT W.A. · CIK 0001600739 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,210 shares Expires 2024-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2024 Filed Feb 12, 2024 22:44 UTC |
SELLERS ROBERT W.A.SVP, Corporate Controller
|
SaleCommon Stock | 12,210 | $87.00 | $1,062,270.00 |
DisclosureSEC source: 0001225208-24-001867 · doc4.xml · nonDerivative · entry 2 SELLERS ROBERT W.A. · CIK 0001600739 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,087.1838 Read SEC document |
| February 12, 2024 Filed Feb 12, 2024 22:44 UTC |
SELLERS ROBERT W.A.SVP, Corporate Controller
|
Exercise / conversionCommon Stock | 12,210 | $36.75 | $448,717.50 |
DisclosureSEC source: 0001225208-24-001867 · doc4.xml · nonDerivative · entry 1 SELLERS ROBERT W.A. · CIK 0001600739 · SVP, Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,297.1838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2024 Filed Feb 8, 2024 23:08 UTC |
STONE HEISZ LESLIEDirector
|
Exercise / conversionDirector Stock Option (Right to Acquire) · Derivative | 7,056 | $0.00 Strike: $36.86 | $0.00 |
DisclosureSEC source: 0001225208-24-001791 · doc4.xml · derivative · entry 3 STONE HEISZ LESLIE · CIK 0001235408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,056 shares Expires 2024-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2024 Filed Feb 8, 2024 23:08 UTC |
STONE HEISZ LESLIEDirector
|
SaleCommon Stock | 7,056 | $86.45 | $609,991.20 |
DisclosureSEC source: 0001225208-24-001791 · doc4.xml · nonDerivative · entry 2 STONE HEISZ LESLIE · CIK 0001235408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,980 Read SEC document |
| February 08, 2024 Filed Feb 8, 2024 23:08 UTC |
STONE HEISZ LESLIEDirector
|
Exercise / conversionCommon Stock | 7,056 | $36.86 | $260,107.44 |
DisclosureSEC source: 0001225208-24-001791 · doc4.xml · nonDerivative · entry 1 STONE HEISZ LESLIE · CIK 0001235408 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2024 Filed Feb 5, 2024 23:37 UTC |
MUSSALLEM MICHAEL ADirector
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 29,350 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001225208-24-001597 · doc4.xml · derivative · entry 7 MUSSALLEM MICHAEL A · CIK 0001204551 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,050 Underlying: Common Stock · 29,350 shares Expires 2024-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2024 Filed Feb 5, 2024 23:37 UTC |
MUSSALLEM MICHAEL ADirector
|
SaleCommon Stock | 12,167 | $87.55 | $1,065,220.85 |
DisclosureSEC source: 0001225208-24-001597 · doc4.xml · nonDerivative · entry 5 MUSSALLEM MICHAEL A · CIK 0001204551 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,485.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023. F5 · price: This transaction was executed in multiple trades at prices ranging from $87.110 to $88.105. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 05, 2024 Filed Feb 5, 2024 23:37 UTC |
MUSSALLEM MICHAEL ADirector
|
SaleCommon Stock | 9,761 | $86.44 | $843,740.84 |
DisclosureSEC source: 0001225208-24-001597 · doc4.xml · nonDerivative · entry 4 MUSSALLEM MICHAEL A · CIK 0001204551 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,652.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023. F4 · price: This transaction was executed in multiple trades at prices ranging from $86.100 to $87.070. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 05, 2024 Filed Feb 5, 2024 23:37 UTC |
MUSSALLEM MICHAEL ADirector
|
SaleCommon Stock | 6,422 | $88.63 | $569,181.86 |
DisclosureSEC source: 0001225208-24-001597 · doc4.xml · nonDerivative · entry 3 MUSSALLEM MICHAEL A · CIK 0001204551 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,413.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $88.210 to $89.200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 05, 2024 Filed Feb 5, 2024 23:37 UTC |
MUSSALLEM MICHAEL ADirector
|
SaleCommon Stock | 1,000 | $89.61 | $89,610.00 |
DisclosureSEC source: 0001225208-24-001597 · doc4.xml · nonDerivative · entry 2 MUSSALLEM MICHAEL A · CIK 0001204551 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,835.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $89.390 to $90.080. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 05, 2024 Filed Feb 5, 2024 23:37 UTC |
MUSSALLEM MICHAEL ADirector
|
Exercise / conversionCommon Stock | 29,350 | $36.75 | $1,078,612.50 |
DisclosureSEC source: 0001225208-24-001597 · doc4.xml · nonDerivative · entry 1 MUSSALLEM MICHAEL A · CIK 0001204551 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,835.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023. Read SEC document |
| February 01, 2024 Filed Feb 1, 2024 22:52 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 7,255 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001225208-24-001384 · doc4.xml · derivative · entry 4 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,760 Underlying: Common Stock · 7,255 shares Expires 2024-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2024 Filed Feb 1, 2024 22:52 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
SaleCommon Stock | 7,255 | $78.29 | $567,993.95 |
DisclosureSEC source: 0001225208-24-001384 · doc4.xml · nonDerivative · entry 2 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,248 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023. Read SEC document |
| February 01, 2024 Filed Feb 1, 2024 22:52 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
Exercise / conversionCommon Stock | 7,255 | $36.75 | $266,621.25 |
DisclosureSEC source: 0001225208-24-001384 · doc4.xml · nonDerivative · entry 1 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023. Read SEC document |
| January 12, 2024 Filed Jan 12, 2024 22:36 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 10,000 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001225208-24-000907 · doc4.xml · derivative · entry 5 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,000 Underlying: Common Stock · 10,000 shares Expires 2024-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 12, 2024 Filed Jan 12, 2024 22:36 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
SaleCommon Stock | 10,000 | $75.67 | $756,700.00 |
DisclosureSEC source: 0001225208-24-000907 · doc4.xml · nonDerivative · entry 2 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,502.6931 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $75.41 to $76.01. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 12, 2024 Filed Jan 12, 2024 22:36 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionCommon Stock | 10,000 | $36.75 | $367,500.00 |
DisclosureSEC source: 0001225208-24-000907 · doc4.xml · nonDerivative · entry 1 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,502.6931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023. Read SEC document |
| January 05, 2024 Filed Jan 6, 2024 00:19 UTC |
MUSSALLEM MICHAEL ADirector
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 29,350 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001225208-24-000480 · doc4.xml · derivative · entry 5 MUSSALLEM MICHAEL A · CIK 0001204551 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 117,400 Underlying: Common Stock · 29,350 shares Expires 2024-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2024 Filed Jan 6, 2024 00:19 UTC |
MUSSALLEM MICHAEL ADirector
|
SaleCommon Stock | 26,850 | $72.94 | $1,958,439.00 |
DisclosureSEC source: 0001225208-24-000480 · doc4.xml · nonDerivative · entry 3 MUSSALLEM MICHAEL A · CIK 0001204551 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,485.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023. F3 · price: This transaction was executed in multiple trades at prices ranging from $72.41 to $73.41. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 05, 2024 Filed Jan 6, 2024 00:19 UTC |
MUSSALLEM MICHAEL ADirector
|
SaleCommon Stock | 2,500 | $73.46 | $183,650.00 |
DisclosureSEC source: 0001225208-24-000480 · doc4.xml · nonDerivative · entry 2 MUSSALLEM MICHAEL A · CIK 0001204551 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,335.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $73.42 to $73.59. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 05, 2024 Filed Jan 6, 2024 00:19 UTC |
MUSSALLEM MICHAEL ADirector
|
Exercise / conversionCommon Stock | 29,350 | $36.75 | $1,078,612.50 |
DisclosureSEC source: 0001225208-24-000480 · doc4.xml · nonDerivative · entry 1 MUSSALLEM MICHAEL A · CIK 0001204551 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,835.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023. Read SEC document |
| December 29, 2023 Filed Dec 29, 2023 21:25 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 14,510 | $0.00 Strike: $36.75 | $0.00 |
DisclosureSEC source: 0001225208-23-011362 · doc4.xml · derivative · entry 4 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,015 Underlying: Common Stock · 14,510 shares Expires 2024-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 29, 2023 Filed Dec 29, 2023 21:25 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
SaleCommon Stock | 14,510 | $76.55 | $1,110,794.19 |
DisclosureSEC source: 0001225208-23-011362 · doc4.xml · nonDerivative · entry 2 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,248 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $76.25 to $76.73. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 29, 2023 Filed Dec 29, 2023 21:25 UTC |
Ullem Scott B.CVP, Chief Financial Officer
|
Exercise / conversionCommon Stock | 14,510 | $36.75 | $533,242.50 |
DisclosureSEC source: 0001225208-23-011362 · doc4.xml · nonDerivative · entry 1 Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,758 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023. Read SEC document |
| December 15, 2023 Filed Dec 15, 2023 22:22 UTC |
Chopra DaveenCVP, TMTT
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 7,000 | $0.00 Strike: $59.26 | $0.00 |
DisclosureSEC source: 0001225208-23-011152 · doc4.xml · derivative · entry 3 Chopra Daveen · CIK 0001740963 · CVP, TMTT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 7,000 shares Expires 2026-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.